The Indian government sent a notice March 3 that it is halting exports of 13 active pharmaceutical ingredients and 13 finished drug products due to concerns about the coronavirus outbreak causing shortages.
The Indian Pharmaceutical Alliance, which represents India’s largest drugmakers, and the Indian Drug Manufacturers’ Association wrote to the government asking to withdraw the restriction, saying the country has a “surplus to meet global demand” for the ingredients and finished drug products and that the restriction hurts the country’s image.
At a meeting March 9, drugmakers reportedly assured the government that they have enough supplies to last until at least May, the Economic Times reported.
The drug industry added that if any unexpected shortages occur, they’ll agree to restrict exports again.
Read the full article here.
More articles on pharmacy:
Coronavirus prompts fear of respiratory drug shortage
Bristol Myers Squibb reveals new branding after Celgene acquisition
Online pharmacy to offer 500 generic drugs for $5 monthly, delivery included
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.